Skip to main content
. 2005 Jul 5;93(2):208–215. doi: 10.1038/sj.bjc.6602686

Table 1. Details of antibodies/techniques used.

Target Supplier Host/type Catalogue number Dilution Detection System
Total-pRb CST Mouse monoclonal 9309 1 : 100 Mouse Envision+
Phospho(S249/T252)-pRb Biosource Rabbit polyclonal 44-584 1 : 1000 Rabbit Envision+
Total-p27 RDI Rabbit polyclonal P27CabrX 1 : 100 Rabbit Envision+
Phospho(T187)-p27 Upstate Rabbit polyclonal 06-996 1 : 100 Rabbit Envision+
p53 NovoCastra Rabbit polyclonal NCL-p53-CM1 1 : 2500 Rabbit Envision+
Cyclin A Neomarkers Mouse monoclonal MS-1061S1 1 : 40 Mouse Envision+
Cyclin E NovoCastra Mouse monoclonal NCL-CYCLIN E 1 : 20 Mouse Envision+
Ki67 Dako Mouse monoclonal M7240 1 : 25 Mouse Envision+
Phospho(S10)-Histone H3 Upstate Rabbit polyclonal 06–570 1 : 1000 Rabbit Envision+
p21 BD Pharmingen Mouse monoclonal 610234 1 : 25 Mouse Envision+
Cleaved-Caspase-3 CST Rabbit polyclonal 9661 1 : 300 Rabbit Envision+
M30 Roche Mouse monoclonal 2 140 349 1 : 200 Mouse Envision+
TUNEL (in situ cell death kit) Roche N/A 1 684 817    

pRb=phosphorylated pRb; phospho-p27=phosphorylated p27; TUNEL=terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labelling.

CST–New England Biolabs (UK) Ltd, Hitchin, Hertfordshire, UK; Biosource–B-1400 Nivelles, Belgium; RDI–Concord MA 01742-3049 USA; Upstate–Dundee, UK; Novocastra–Newcastle upon Tyne, UK; Neomarkers–Lab Vision (UK) Ltd, Newmarket, Suffolk, UK; Dako–Ely, Cambridgeshire, UK; BD Pharmingen–Cowley, Oxford, UK.